ISO 13485 Audit Readiness: How to Pass with Confidence

With ISO 13485 audits tightening worldwide, unprepared medical-device companies face major risks in 2026 and beyond. The regulatory climate has changed fast: global authorities are aligning standards, increasing unannounced inspections, and raising expectations of documentation quality.
ISO 13485 audit readiness

Updated: 8th July 2026

Reviewed by: David Small BSc (Hons), MSc, MTOPRA (Founder & CEO)

ISO 13485 Audit Readiness: How to Pass with Confidence

Achieving ISO 13485 certification is a significant milestone for any medical device manufacturer, but maintaining compliance requires far more than preparing for an annual audit. The most successful organisations don’t treat audit readiness as a last-minute exercise—they build it into their Quality Management System (QMS), making compliance part of everyday operations.

Whether you’re preparing for an initial certification audit, a surveillance audit or recertification, auditors are looking for one thing above all else: objective evidence that your Quality Management System is implemented, effective and consistently followed throughout your organisation.

Preparing early helps reduce stress, minimise non-conformities and demonstrate confidence in your quality processes. More importantly, it ensures your organisation continues to manufacture safe, effective and compliant medical devices while meeting regulatory expectations.

If you need a complete introduction to the ISO 13485 standard before focusing on audit preparation, our What is ISO 13485? guide explains the requirements, certification process and Quality Management System fundamentals.

What Is ISO 13485 Audit Readiness?

ISO 13485 audit readiness is the process of ensuring your Quality Management System remains compliant and capable of demonstrating conformity with ISO 13485 requirements at any time—not simply when an audit has been scheduled.

True audit readiness means maintaining accurate documentation, following approved procedures, training personnel, managing suppliers, controlling risks and continually monitoring the effectiveness of your Quality Management System throughout the year.

Organisations may undergo several different types of ISO 13485 audits during the lifetime of their certification, including:

Initial Certification Audit

An initial certification audit is performed by a Certification Body to determine whether your Quality Management System satisfies all applicable requirements of ISO 13485 before certification is granted.

Surveillance Audits

Once certified, organisations are typically audited annually through surveillance audits. These assessments verify that the Quality Management System continues to operate effectively and remains compliant as the organisation evolves.

Recertification Audits

Every certification cycle concludes with a recertification audit. This comprehensive assessment evaluates the ongoing effectiveness of the Quality Management System and confirms continued certification.

Internal Audits

Internal audits are equally important. They allow organisations to identify weaknesses, verify compliance and implement corrective actions before external auditors identify non-conformities.

Organisations that continuously monitor their Quality Management System generally experience smoother audits, fewer findings and significantly less disruption than those who prepare only when an audit date has been confirmed.

Why ISO 13485 Audit Readiness Matters

Many organisations view an ISO 13485 audit as a one-day inspection. In reality, successful audits are the result of months—or even years—of consistent quality management practices.

Maintaining continuous audit readiness provides a number of important benefits:

  • Reduces the likelihood of major and minor non-conformities.
  • Improves confidence during Certification Body audits.
  • Demonstrates effective management commitment.
  • Strengthens regulatory compliance under EU MDR, UK MDR and other international regulations.
  • Improves consistency across design, manufacturing and post-market activities.
  • Builds customer confidence and supports supplier relationships.
  • Reduces disruption caused by last-minute document reviews and corrective actions.

Perhaps most importantly, continuous audit readiness demonstrates that quality is embedded within the organisation rather than existing solely to satisfy auditors.

A mature Quality Management System should produce evidence of compliance naturally through normal business operations—not through intensive preparation immediately before an audit.

What Do ISO 13485 Auditors Look For?

ISO 13485 auditors are not trying to catch organisations out—they are looking for objective evidence that your Quality Management System is implemented, effective and consistently followed throughout the organisation.

Rather than simply reviewing documentation, auditors will assess whether your processes are understood by employees, appropriately controlled and capable of consistently delivering safe, compliant medical devices.

Below are some of the key areas that Certification Bodies routinely examine during ISO 13485 audits.

Document Control and Quality Records

One of the first areas auditors review is document control. They need confidence that employees are working from current, approved procedures and that obsolete documentation has been removed from circulation.

Expect auditors to examine:

  • Quality Manual (where applicable)
  • Standard Operating Procedures (SOPs)
  • Work Instructions
  • Quality Policy and Objectives
  • Controlled Forms and Templates
  • Training Records
  • Validation Reports
  • Internal Audit Reports
  • CAPA Records
  • Management Review Minutes
  • Complaint Files
  • Supplier Records

Auditors will also verify that documents are appropriately reviewed, approved, version controlled and retained in accordance with your documented procedures.

Missing approvals, inconsistent revision histories and outdated procedures are common causes of audit findings.

Management Responsibility and Leadership

ISO 13485 places significant responsibility on top management to demonstrate leadership and commitment to the Quality Management System.

Auditors typically look for evidence that senior management actively supports quality rather than simply delegating responsibility to the Quality Manager.

They may review:

  • Quality Objectives
  • Management Review Meetings
  • Resource Planning
  • Customer Feedback
  • Quality Performance Indicators
  • Continuous Improvement Activities

Employees should also understand the organisation’s quality policy and appreciate how their individual roles contribute to maintaining compliance.

Risk Management

Risk management should be integrated throughout the Quality Management System rather than existing as a standalone document.

Auditors will expect to see that risks are continually identified, evaluated, controlled and reviewed throughout the entire medical device lifecycle.

They may examine:

  • Risk Management Plans
  • Hazard Identification
  • Risk Analyses
  • Risk Control Measures
  • Residual Risk Evaluations
  • Production Feedback
  • Complaint Trends
  • Post-Market Surveillance Data

Risk Management Files should clearly demonstrate traceability between identified hazards, implemented controls and verification of effectiveness.

Design and Development Controls

For manufacturers responsible for product design, auditors will carefully review design and development activities to ensure they are fully controlled and documented.

Typical evidence includes:

  • Design Plans
  • Design Inputs
  • Design Outputs
  • Design Reviews
  • Design Verification
  • Design Validation
  • Design Transfer
  • Design Changes
  • Design History Records

Auditors often trace a single design requirement from its original specification through verification and validation to confirm that the process is fully documented and traceable.

Patient Guard infographic showing the eight key areas reviewed during an ISO 13485 audit, including quality management, risk management, design controls, document control, supplier management, production controls, CAPA and internal audits.

Common ISO 13485 Audit Findings (and How to Avoid Them)

Even organisations with well-established Quality Management Systems occasionally receive audit findings. In many cases, the issues identified are not the result of poor quality systems, but rather inconsistent implementation, inadequate documentation or ineffective monitoring.

Understanding the most common non-conformities can help organisations strengthen their Quality Management System before an external audit takes place.

1. Poor Document Control

Outdated procedures, missing approvals and inconsistent document revisions remain some of the most frequently identified audit findings.

Auditors expect employees to use only current, approved documents. If obsolete procedures remain accessible or controlled documents are not reviewed regularly, this may result in non-conformities.

To minimise risk:

  • Maintain a robust document control procedure.
  • Regularly review controlled documents.
  • Remove obsolete versions from circulation.
  • Ensure revision histories are complete.
  • Verify employees are using current documentation.

2. Incomplete Corrective and Preventive Action (CAPA)

Many organisations investigate non-conformities but fail to demonstrate that corrective actions have actually prevented recurrence.

Auditors frequently identify:

  • Poor root cause analysis.
  • CAPAs closed prematurely.
  • Missing effectiveness checks.
  • Repeat non-conformities.
  • Incomplete investigation records.

An effective CAPA system should demonstrate not only what was corrected, but why the issue occurred and how recurrence has been prevented.

3. Inadequate Staff Training and Competency

ISO 13485 requires personnel performing quality-related activities to be competent based on appropriate education, training, skills and experience.

Auditors often discover:

  • Missing training records.
  • Employees unfamiliar with current procedures.
  • Incomplete induction training.
  • Lack of competency assessments.
  • No evidence of refresher training.

Staff should understand both their individual responsibilities and how their work contributes to maintaining the Quality Management System.

4. Weak Supplier Management

External suppliers play a critical role in maintaining product quality, yet supplier management remains a common source of audit findings.

Examples include:

  • Missing supplier evaluations.
  • Outdated supplier approvals.
  • Infrequent supplier monitoring.
  • Poor change notification processes.
  • Incomplete Quality Agreements.

Manufacturers should ensure supplier oversight is proportionate to the level of risk associated with the supplied product or service.

5. Ineffective Risk Management

Risk Management Files should remain living documents throughout the product lifecycle.

Common issues include:

  • Risk files not updated after design changes.
  • Complaint trends not feeding back into risk assessments.
  • Missing links between identified hazards and implemented controls.
  • Poor traceability between verification activities and risk control measures.
  • Outdated benefit-risk evaluations.

Auditors expect risk management to support design, manufacturing and post-market activities—not exist independently of them.

6. Validation Records That Lack Evidence

Validation activities should provide objective evidence that processes consistently achieve their intended results.

Audit findings commonly arise from:

  • Incomplete validation protocols.
  • Missing validation reports.
  • Lack of documented acceptance criteria.
  • Failure to revalidate following significant process changes.
  • Poor traceability between validation activities and approved procedures.

Validation should extend beyond manufacturing processes and may also include software, sterilisation, cleaning, packaging and other critical processes where applicable.

7. Internal Audits That Add Little Value

Internal audits should identify opportunities for improvement before Certification Bodies do.

Auditors frequently identify internal audit programmes that:

  • Cover only selected clauses.
  • Lack auditor independence.
  • Fail to investigate root causes.
  • Do not verify corrective actions.
  • Repeat the same findings year after year.

An effective internal audit programme should continually evaluate the effectiveness of the Quality Management System rather than simply confirming compliance.

8. Poor Management Review

Management Review meetings demonstrate that senior leadership actively supports the Quality Management System.

Common weaknesses include:

  • Infrequent meetings.
  • Missing mandatory inputs.
  • Limited discussion of quality objectives.
  • No documented actions.
  • Failure to review opportunities for improvement.

Management Review should be a strategic exercise that drives continual improvement rather than an administrative requirement completed solely for certification purposes.

9. Incomplete Complaint Handling and Post-Market Feedback

Customer complaints, servicing records and post-market surveillance activities provide valuable information about device performance.

Audit findings often result from:

  • Delayed complaint investigations.
  • Missing trend analysis.
  • Inadequate linkage to CAPA.
  • Failure to update Risk Management Files.
  • Poor documentation of investigation outcomes.

Effective complaint handling demonstrates that organisations continuously monitor product performance after devices have been placed on the market.

10. Treating Audit Preparation as a Last-Minute Exercise

Perhaps the most common issue of all is preparing for ISO 13485 audits only after an audit date has been confirmed.

Successful organisations maintain continuous audit readiness by regularly reviewing documentation, conducting internal audits, monitoring quality objectives and addressing issues as they arise.

When quality activities become part of everyday operations, external audits become considerably less stressful and significantly more predictable.

ISO 13485 Audit Preparation Checklist

Successful ISO 13485 audits are rarely the result of intensive preparation during the weeks before an inspection. Instead, they are the outcome of a well-maintained Quality Management System that has been consistently implemented, monitored and improved throughout the year.

Before your Certification Body arrives, it is good practice to verify that the following areas have been reviewed and are fully up to date.

Quality Management System Documentation

Ensure your Quality Management System documentation is complete, current and readily available.

Review:

  • Quality Manual (where applicable).
  • Standard Operating Procedures (SOPs).
  • Work Instructions.
  • Controlled Forms and Templates.
  • Document revision histories.
  • Document approval records.
  • Obsolete document controls.

Employees should have easy access to the latest approved versions of all controlled documents.

Internal Audit Programme

Confirm that internal audits have been completed according to the planned audit schedule.

Verify:

  • All planned audits have been completed.
  • Audit reports have been approved.
  • Non-conformities have been addressed.
  • Corrective actions have been verified.
  • Outstanding actions have been closed.

Auditors frequently review internal audit records as evidence that the Quality Management System is being effectively monitored.

Management Review

Ensure Management Review meetings have been conducted as planned and include all required inputs.

Typical agenda items include:

  • Internal audit results.
  • Customer feedback.
  • Complaint trends.
  • Supplier performance.
  • CAPA status.
  • Risk Management updates.
  • Quality Objectives.
  • Resource requirements.
  • Opportunities for continual improvement.

Management Review records should clearly demonstrate active involvement from senior management.

Staff Training and Competency

Confirm that personnel performing quality-related activities remain competent for their assigned responsibilities.

Review:

  • Training records.
  • Competency assessments.
  • Induction training.
  • Refresher training.
  • Procedure updates.
  • Job-specific qualifications.

Employees should also be familiar with the procedures they follow and understand how their work contributes to maintaining product quality.

Risk Management

Risk Management Files should accurately reflect the current design, manufacturing processes and post-market experience of the device.

Review:

  • Risk Management Plans.
  • Hazard analyses.
  • Risk evaluations.
  • Risk control measures.
  • Residual risk assessments.
  • Benefit-risk evaluations.
  • Post-market feedback.
  • Complaint trends.

Risk Management documentation should demonstrate continuous review rather than remaining unchanged after product launch.

Supplier Management

Verify that supplier controls remain current and appropriate.

Check:

  • Approved supplier lists.
  • Supplier evaluations.
  • Supplier monitoring records.
  • Supplier audits.
  • Quality Agreements.
  • Supplier performance trends.
  • Change notifications.

High-risk suppliers should receive greater oversight than suppliers providing low-risk products or services.

Validation Activities

Review all validation records to ensure they remain current and appropriately documented.

This may include:

  • Process validation.
  • Software validation.
  • Cleaning validation.
  • Packaging validation.
  • Sterilisation validation.
  • Equipment qualification.
  • Revalidation following significant changes.

Validation evidence should clearly demonstrate that processes consistently achieve their intended results.

Corrective and Preventive Action (CAPA)

Review all open and recently closed CAPAs.

Confirm that:

  • Root causes have been identified.
  • Corrective actions have been implemented.
  • Effectiveness has been verified.
  • Similar issues have not recurred.
  • CAPAs have been formally closed.

Auditors often spend significant time reviewing CAPA records because they provide valuable insight into how an organisation responds to quality issues.

Complaints and Post-Market Surveillance

Ensure customer feedback is appropriately managed and incorporated into continual improvement activities.

Review:

  • Complaint investigations.
  • Trend analysis.
  • Vigilance records.
  • Corrective actions.
  • Risk Management updates.
  • Post-Market Surveillance reports.

Auditors expect organisations to learn from real-world experience and continually improve their Quality Management System.

Prepare Your Team

Finally, ensure employees understand their responsibilities during the audit.

Staff should be able to:

  • Explain their role.
  • Describe the procedures they follow.
  • Locate controlled documentation.
  • Demonstrate how records are maintained.
  • Escalate quality issues appropriately.

Confidence comes from familiarity. Employees should answer questions honestly, refer to documented procedures where necessary and avoid guessing if they are uncertain.

Why This Matters

Organisations that maintain this level of preparedness throughout the year typically experience smoother certification, surveillance and recertification audits. More importantly, they demonstrate that quality is embedded within everyday operations rather than treated as a last-minute compliance exercise.

What Happens During an ISO 13485 Audit?

Understanding what to expect during an ISO 13485 audit can significantly reduce stress and help your team feel more confident. Although every Certification Body has its own audit methodology, most ISO 13485 audits follow a similar structure.

Auditors are not trying to find fault wherever possible. Their role is to collect objective evidence that your Quality Management System has been effectively implemented and complies with ISO 13485 requirements.

A typical audit will include the following stages.

Opening Meeting

The audit begins with an opening meeting involving the auditor and key members of your management team.

During this meeting the auditor will typically:

  • Introduce the audit team.
  • Confirm the audit scope and objectives.
  • Explain the audit schedule.
  • Identify the departments and processes to be reviewed.
  • Discuss any logistical arrangements.
  • Answer any initial questions.

This meeting helps ensure everyone understands how the audit will be conducted before detailed assessments begin.

Documentation Review

The auditor will then begin reviewing your Quality Management System documentation.

Depending on the scope of the audit, this may include:

  • Quality Manual (where applicable).
  • Standard Operating Procedures.
  • Work Instructions.
  • Risk Management documentation.
  • Validation reports.
  • Internal audit reports.
  • CAPA records.
  • Management Review minutes.
  • Supplier records.
  • Training records.
  • Complaint files.
  • Post-Market Surveillance documentation.

Rather than simply confirming documents exist, auditors will assess whether they are current, approved, controlled and consistently implemented.

Employee Interviews

Auditors frequently speak directly with employees responsible for quality-related activities.

These conversations are intended to confirm that personnel understand:

  • Their responsibilities.
  • The procedures they follow.
  • How quality records are maintained.
  • How issues are reported.
  • How changes are controlled.

Employees should answer questions honestly and explain how they perform their normal day-to-day activities. If they are unsure of an answer, referring to the relevant documented procedure is entirely acceptable.

Process and Facility Review

Auditors will often observe operational activities to verify that documented procedures are being followed in practice.

This may include reviewing:

  • Manufacturing activities.
  • Incoming inspection.
  • Equipment maintenance.
  • Calibration.
  • Environmental controls.
  • Product identification.
  • Traceability.
  • Storage conditions.
  • Labelling.
  • Release procedures.

The objective is to confirm that actual working practices reflect documented Quality Management System procedures.

Traceability Exercises

One of the most common audit techniques is a traceability exercise.

The auditor may select a medical device, batch or production record and ask the organisation to demonstrate complete traceability throughout its lifecycle.

Examples include tracing:

  • Raw materials to finished products.
  • Design inputs to design outputs.
  • Risk controls to verification activities.
  • Customer complaints to CAPA.
  • Supplier approvals to purchased components.
  • Training records to specific job roles.

Strong traceability demonstrates that the Quality Management System is integrated rather than operating as disconnected processes.

Recording Audit Findings

If the auditor identifies areas that do not fully comply with ISO 13485 requirements, these will normally be discussed during the audit rather than being presented as a surprise at the end of the visit.

Audit findings may include:

  • Opportunities for Improvement (OFIs).
  • Minor Non-Conformities.
  • Major Non-Conformities.

Many findings are relatively straightforward to address, particularly when organisations already operate an effective CAPA process.

The objective should always be continual improvement rather than simply achieving a perfect audit.

Closing Meeting

At the conclusion of the audit, the auditor will hold a closing meeting with management.

This meeting typically includes:

  • A summary of the audit.
  • Positive observations.
  • Areas of good practice.
  • Opportunities for Improvement.
  • Minor and Major Non-Conformities (if identified).
  • Expected timescales for corrective actions.
  • Next steps in the certification process.

This provides an opportunity to clarify any observations before the formal audit report is issued.

Remember: Auditors Are Looking for Evidence, Not Perfection

Many organisations approach an ISO 13485 audit believing they must demonstrate perfection. In reality, auditors recognise that no Quality Management System is flawless.

What they expect to see is a mature organisation that understands its processes, identifies issues promptly, implements effective corrective actions and demonstrates a genuine commitment to continual improvement.

An organisation that can clearly demonstrate control of its Quality Management System will often perform far better than one that simply presents extensive documentation without evidence that it is being followed in practice.

Maintaining Continuous ISO 13485 Audit Readiness

The most successful medical device manufacturers do not prepare for ISO 13485 audits once a year—they build audit readiness into the day-to-day operation of their Quality Management System.

Rather than viewing audits as isolated events, organisations should establish processes that continually monitor compliance, identify opportunities for improvement and ensure quality records remain accurate, complete and up to date.

When audit readiness becomes part of an organisation’s culture, external audits become significantly less disruptive and far more predictable.

Continuous audit readiness should include:

  • Regular internal audits against planned audit schedules.
  • Ongoing review of Quality Management System documentation.
  • Timely completion and verification of CAPA activities.
  • Routine Management Review meetings.
  • Continuous monitoring of supplier performance.
  • Regular review of Risk Management Files.
  • Validation of new or modified processes.
  • Employee training and competency assessments.
  • Analysis of complaints, customer feedback and Post-Market Surveillance data.
  • Monitoring quality objectives and continual improvement initiatives.

Organisations that consistently maintain these activities are generally able to demonstrate compliance with confidence, regardless of when an external audit takes place.

How Patient Guard Can Help

Preparing for an ISO 13485 audit can be challenging, particularly for organisations undergoing certification for the first time or managing increasingly complex regulatory requirements.

At Patient Guard, we work with medical device and IVD manufacturers throughout the UK, Europe and internationally to develop robust Quality Management Systems that are designed for long-term compliance—not simply to pass the next audit.

Our consultants can support your organisation with:

  • ISO 13485 implementation.
  • Internal audits.
  • Mock Certification Body audits.
  • Gap assessments.
  • CAPA investigations.
  • Supplier Quality Management.
  • Risk Management (ISO 14971).
  • Validation activities.
  • Technical Documentation.
  • Ongoing regulatory and quality support.

Whether you are preparing for your initial certification audit, an annual surveillance audit or recertification, we can help you identify potential gaps, strengthen your Quality Management System and improve confidence before your Certification Body arrives.

If you would like to discuss your upcoming ISO 13485 audit or Quality Management System, contact Patient Guard today to speak with one of our regulatory specialists.

Conclusion

ISO 13485 audit readiness is not about preparing a collection of documents a few weeks before an audit—it is about demonstrating that your Quality Management System consistently delivers safe, effective and compliant medical devices every day.

Certification Bodies are looking for objective evidence that documented procedures are understood, implemented and continually improved throughout the organisation. When documentation is controlled, employees are well trained, risks are effectively managed and continual improvement is embedded within the Quality Management System, audits become far less daunting.

By maintaining continuous audit readiness, organisations can reduce non-conformities, improve operational efficiency, strengthen regulatory compliance and build greater confidence with customers, Certification Bodies and regulatory authorities.

Ultimately, the organisations that perform best during ISO 13485 audits are those that treat quality as an integral part of their business—not simply as a requirement for certification.

Frequently Asked Questions About ISO 13485 Audits

It’s the state of being continuously prepared for internal, external, and regulatory audits under the ISO 13485 standard. Readiness means your QMS is fully implemented, documented, and demonstrably effective — not just when an audit date looms.

Any organisation involved in designing, manufacturing, or distributing medical devices. Even subcontractors performing critical processes fall under the standard’s scope.

Expect non-conformities that demand immediate corrective action. Major findings can suspend certification or delay product approvals, leading to costly disruptions and reputational damage.

Internal audits are required at planned intervals, typically annually or per process risk. External certification audits occur every three years, with surveillance visits in between.

ISO 13485 underpins the EU MDR by demonstrating systematic control over design, production, and post-market activities. If your QMS meets ISO 13485, you’ve already built most of the MDR framework.

Absolutely. Our specialists conduct mock audits, gap assessments, and CAPA reviews tailored to your business size and risk profile. We help you pass the real thing without breaking a sweat.

References

This guide is based on the following international standards, legislation and official regulatory guidance relating to ISO 13485 audit readiness, Quality Management Systems (QMS) and medical device regulatory compliance.

Organisation Reference Why it's relevant
International Organization for Standardization (ISO) ISO 13485:2016 – Medical Devices – Quality Management Systems – Requirements for Regulatory Purposes Defines the internationally recognised Quality Management System requirements that certification bodies audit against when assessing medical device manufacturers.
European Union Regulation (EU) 2017/745 on Medical Devices (MDR) Requires manufacturers to establish, document and maintain an appropriate Quality Management System throughout the medical device lifecycle.
International Organization for Standardization (ISO) ISO 14971:2019 – Medical Devices – Application of Risk Management to Medical Devices Provides the internationally recognised framework for integrating risk management into Quality Management Systems, design controls and audit activities.
U.S. Food and Drug Administration (FDA) Quality Management System Regulation (QMSR) Explains the FDA's Quality Management System Regulation and its alignment with ISO 13485, helping manufacturers prepare for compliance with U.S. quality system requirements.
U.S. Food and Drug Administration (FDA) Medical Devices; Quality System Regulation Amendments (Final Rule) Publishes the FDA's final rule establishing the Quality Management System Regulation (QMSR), providing the legal basis for the transition from the legacy Quality System Regulation.

Quality management standards and regulatory requirements continue to evolve. Organisations should always consult the latest published standards, legislation and official regulatory guidance when preparing for certification audits and maintaining compliant Quality Management Systems for medical devices.

David Small BSc (Hons), MSc, MTOPRA

David Small BSc (Hons), MSc, MTOPRA

Reviewed by
David Small, BSc (Hons), MSc, MTOPRA
Founder & CEO |
20+ years in medical device regulatory affairs,  MDR/IVDR compliance and quality systems.

Patient Guards Recent Posts

Cosmetic Product Safety Report (CPSR): A Complete Guide to UK Cosmetic Compliance

Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.

Read More »

IVDR PMPF Explained: A Complete Guide to Post-Market Performance Follow-up

Post-Market Performance Follow-up (PMPF) is a fundamental requirement under the EU In Vitro Diagnostic Regulation (IVDR), ensuring that manufacturers continually monitor the scientific validity, analytical performance and clinical performance of their in vitro diagnostic medical devices after CE marking. This guide explains IVDR PMPF requirements, PMPF Plans, PMPF Reports, Annex XIII expectations and how ongoing performance monitoring supports continued regulatory compliance throughout the device lifecycle.

Read More »

IVDR Scientific Validity Explained: A Complete Guide for Manufacturers

Scientific Validity is the first pillar of IVDR Performance Evaluation and provides the scientific foundation demonstrating that an analyte or biomarker is associated with a specific clinical condition or physiological state. This guide explains Scientific Validity under Regulation (EU) 2017/746, including literature reviews, Scientific Validity Reports, Annex XIII requirements, evidence appraisal and how Scientific Validity supports successful CE marking.

Read More »

Patient Guards Related Services

Patient Guards Regulatory Tools

Need Training?

Do you need training on Quality Management Systems or EU MDR/ EU IVDR? then check out our training courses.

Share this guide:
Posted on Google Google
Munna P profile picture
Munna P
52 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Working with the Patient Guard team has been a great experience throughout our MHRA and ISO 13485 documentation journey. Their expertise, structured approach, and practical guidance helped our team build a robust quality management system while keeping us aligned with regulatory expectations. The collaboration was professional, responsive, and focused on finding solutions rather than simply identifying issues. A special thank you to Alex and Steve for their outstanding coordination, responsiveness, and continuous support throughout the project. They were always approachable, provided valuable feedback, and worked closely with our team to resolve challenges efficiently. Their commitment made a significant difference in keeping our documentation effort on track. I highly recommend Patient Guard to any healthcare or MedTech organization looking for experienced regulatory and quality system partners for MHRA, ISO 13485, and broader medical device compliance initiatives. Thank you again to the entire Patient Guard team for being such reliable partners.
Posted on Google Google
Peter Reeve profile picture
Peter Reeve
79 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
STEPPER design, manufacture & distribute eyewear across the globe. With the increasingly complex landscape concerning the placing of Mecial Devices onto the market, we realised we needed professional guidance. We found Patient Guard via a simple internet search and are delighted we did! They provide a pragmatic solution to our needs, are totally reliable & always available to answer our (often simplistic) questions. They are highly efficient & responsive to what is a changing picture in our world and nothing is too much trouble. We have a much better understanding of regulatory affairs and our responsibilities as manufacturers & distributors and they support us in navigating the requirements in different territories. Updating our Declaration of Conformity, ensuring our labelling is compliant and acting as our PRRC are the key areas of their service for us.
Posted on Google Google
Derek Timm profile picture
Derek Timm
79 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
For those companıes lookıng to comply to ISO standards and ın partıcular ISO13485 whıch to be honest ıs a nıghtmare I would strongly suggest goıng to the professıonals as ındeed we dıd by joınıng forces wıth Patıent Guard Ltd The staff are fantastıc nothıng ıs too much trouble and as a medıcal supply company we sımply cannot lıve wıthout them Thanks ın partıcular to Alex and Steve for all the hard work and our best regards from Dan Medıca South Lımıted
Posted on Google Google
BMSCriticalCare profile picture
BMSCriticalCare
116 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Great service, very helpful and always willing to answer any questions we have,
Posted on Google Google
Thomson Software profile picture
Thomson Software
787 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Alex Lewis of PatientGuard guided us through the ISO13485 process in a thorough, systematic and efficient manner. He was friendly, patient and willing to go the extra mile. Excellent service.
Verified by Trustindex
Trustindex verified badge is the Universal Symbol of Trust. Only the greatest companies can get the verified badge who has a review score above 4.5, based on customer reviews over the past 12 months. Read more

Most Popular

Cosmetic Product Safety Report (CPSR): A Complete Guide to UK Cosmetic Compliance

Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.

Read More »

IVDR PMPF Explained: A Complete Guide to Post-Market Performance Follow-up

Post-Market Performance Follow-up (PMPF) is a fundamental requirement under the EU In Vitro Diagnostic Regulation (IVDR), ensuring that manufacturers continually monitor the scientific validity, analytical performance and clinical performance of their in vitro diagnostic medical devices after CE marking. This guide explains IVDR PMPF requirements, PMPF Plans, PMPF Reports, Annex XIII expectations and how ongoing performance monitoring supports continued regulatory compliance throughout the device lifecycle.

Read More »

IVDR Scientific Validity Explained: A Complete Guide for Manufacturers

Scientific Validity is the first pillar of IVDR Performance Evaluation and provides the scientific foundation demonstrating that an analyte or biomarker is associated with a specific clinical condition or physiological state. This guide explains Scientific Validity under Regulation (EU) 2017/746, including literature reviews, Scientific Validity Reports, Annex XIII requirements, evidence appraisal and how Scientific Validity supports successful CE marking.

Read More »

IVDR Performance Evaluation Explained: A Complete Guide for Manufacturers

Performance Evaluation is one of the most important requirements under the EU In Vitro Diagnostic Regulation (IVDR). Every manufacturer must demonstrate that their in vitro diagnostic medical device achieves its intended purpose through robust scientific validity, analytical performance and clinical performance evidence. This guide explains every stage of IVDR Performance Evaluation, including Performance Evaluation Plans (PEPs), Performance Evaluation Reports (PERs), Post-Market Performance Follow-up (PMPF) and how Performance Evaluation supports successful CE marking under Regulation (EU) 2017/746.

Read More »
patient guard
Patient Guard

Sign up to our newsletter

Be the first to hear industry news and how Patient Guard can help you.

Get the latest updates on medical device regulation

Sign up to our newsletter and we’ll deliver news and insights straight to your inbox.

Get the Medical Device Technical Checklist

Thank you! The checklist is now ready to download.